Vivo Bio Tech Ltd
Vivo Bio Tech Ltd (VIVOBIOT) last traded at ₹18.8, a market capitalisation of ₹41.7 crore. Over the past 52 weeks the stock has ranged between ₹17.6 and ₹41.5. Vivo Bio Tech Ltd last reported results for the quarter ended Jun 2026, with sales of ₹14.28 crore and net profit of ₹0.19 crore. Vivo Bio Tech Ltd’s annual general meeting is scheduled for 30 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Vivo Bio Tech Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Vivo Bio Tech Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹14.28 cr, up 14.1% from ₹12.51 cr a year earlier. Net profit was ₹0.19 cr, down 85.8% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12.04 | 12.21 | 12.29 | 12.51 | 13.11 | 13.51 | 14.2 | 14.28 |
| Expenses | 6.45 | 6.67 | 7.27 | 7.03 | 7.69 | 8.02 | 9.75 | 9.23 |
| Operating profit | 5.59 | 5.54 | 5.02 | 5.48 | 5.42 | 5.49 | 4.45 | 5.05 |
| OPM % | 46.43% | 45.37% | 40.85% | 43.80% | 41.34% | 40.64% | 31.34% | 35.36% |
| Other income | 4.63 | 0.01 | 0.15 | 0.14 | 0.13 | 0.14 | 0.03 | 0.06 |
| Interest | 2.06 | 1.84 | 1.68 | 1.5 | 1.47 | 1.4 | 1.48 | 1.24 |
| Depreciation | 2.29 | 2.25 | 2.25 | 2.64 | 2.57 | 2.66 | 2.75 | 3.53 |
| Profit before tax | 5.87 | 1.46 | 1.24 | 1.48 | 1.51 | 1.57 | 0.25 | 0.34 |
| Tax % | 10.73% | 43.84% | 14.52% | 9.46% | 42.38% | 20.38% | 2,164.00% | 44.12% |
| Net profit | 5.23 | 0.82 | 1.06 | 1.34 | 0.87 | 1.25 | -5.16 | 0.19 |
| EPS (₹) | 3.51 | 0.51 | 0.62 | 0.67 | 0.39 | 0.57 | -2.33 | 0.09 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Vivo Bio Tech Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 51.78 | 51.39 | 52.23 | 45.45 | 46.67 | 53.33 | 55.1 |
| Operating profit | 17.8 | 16.09 | 21.84 | 21.26 | 20.56 | 20.85 | 20.41 |
| OPM % | 34.38% | 31.31% | 41.82% | 46.78% | 44.05% | 39.10% | 37.04% |
| Net profit | 5.68 | 2.2 | 2.65 | 2.53 | 7.28 | -1.71 | -2.85 |
| EPS (₹) | 4.23 | 1.54 | 1.78 | 1.70 | 4.24 | -0.77 | -1.28 |
TTM is the trailing twelve months to the most recent quarter.
Vivo Bio Tech Ltd growth and returns
- 10 Years
- 6%
- 5 Years
- 1%
- 3 Years
- 1%
- TTM
- 12%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -134%
- 10 Years
- -7%
- 5 Years
- -27%
- 3 Years
- -12%
- 1 Year
- -50%
- 10 Years
- 7%
- 5 Years
- 3%
- 3 Years
- 2%
- Last Year
- -2%
Vivo Bio Tech Ltd shareholding pattern
Promoters held 30.62% at Jun 2026, down from 39.07% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 42.08% | 38.89% | 40.85% | 39.07% | 35.17% | 35.17% | 35.43% | 30.62% |
| Public | 57.91% | 61.12% | 59.16% | 60.94% | 64.84% | 64.84% | 64.58% | 69.39% |
| No. of shareholders | 19,545 | 21,167 | 21,935 | 21,865 | 21,647 | 21,622 | 21,427 | 21,225 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Vivo Bio Tech Ltd’s AGM?
Vivo Bio Tech Ltd’s annual general meeting is scheduled for 30 Sept 2026.
- AGM39th Annual General Meeting and re-appointment of Whole-Time Directors
See the full results calendar for every Indian company reporting in the next 30 days.
Vivo Bio Tech Ltd corporate filings
- Expiry Of WarrantsCompany Updatelow impact
Cruxal's analysis: The company has formally disclosed the expiry of warrants, a routine corporate action…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Maxcell Communication India Pvt LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Vivo Bio Tech Limited has witnessed a change in shareholding as Maxcell Communication…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dwight Technologies Pvt LtdInsider Trading / SASThigh impact
Cruxal's analysis: Dwight Technologies Private Limited has acquired 12 lakh equity shares of Vivo Bio Tech…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for P K L Solution Pvt LtdInsider Trading / SASTlow impact
Cruxal's analysis: Vivo Bio Tech Limited has reported a change in shareholding following an off-market…
Read the full analysis - Board Meeting Outcome for Outcome Of Board MeetingOtherslow impact
Cruxal's analysis: Vivo Bio Tech Limited has announced that its 39th Annual General Meeting is scheduled for…
Read the full analysis - Expiry Of WarrantsCompany Updatelow impact
Cruxal's analysis: The company has issued a formal notification regarding the expiry of warrants. This is a…
Read the full analysis - Expiry Of WarrantsCompany Updatelow impact
Cruxal's analysis: The company has formally notified the exchange regarding the expiry of warrants. No…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Vivo Bio Tech Ltd
Cruxal reads every Vivo Bio Tech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.